Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Philippe Moreau
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Procedures
Physiology
Anatomy
Concepts & Ideas
Genes & Molecular Sequences
Sign-in to see full Profile
Network (preview)
63
Harousseau, Jean-Luc
52
Carosella, Edgardo
35
Milpied, Noël
29
Dausset, Jean
24
Rouas-Freiss, Nathalie
20
Bataille, Régis
18
Mahé, Béatrice
17
Avet-Loiseau, Hervé
15
Paul, P
13
Rapp, Marie-Josée
12
Attal, Michel
11
Morineau, Nadine
10
Robillard, Nelly
10
Menier, Catherine
10
Facon, Thierry
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Philippe Moreau (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Cahu Xavier; Rialland Fanny; Touzeau Cyrille; Chevallier Patrice; Guillaume Thierry; Delaunay Jacques; Ayari Sameh; Dubruille Viviane; Le Gouill Steven; Mahe Beatrice; Gastinne Thomas; Blin Nicolas; Saulquin Beatrice; Harousseau Jean-Luc; Moreau Philippe; Mohty Mohamad
Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1531-7.
-
2009: Brissot E; Chevallier P; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Flandrois G; Devys A; Stocco V; Cesbron A; Dehaut F; Moreau P; Harousseau J-L; Mohty M
Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors.
Bone marrow transplantation 2009;44(9):613-5.
-
2009: Avet-Loiseau Hervé; Li Cheng; Magrangeas Florence; Gouraud Wilfried; Charbonnel Catherine; Harousseau Jean-Luc; Attal Michel; Marit Gerald; Mathiot Claire; Facon Thierry; Moreau Philippe; Anderson Kenneth C; Campion Loïc; Munshi Nikhil C; Minvielle Stéphane
Prognostic significance of copy-number alterations in multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4585-90.
-
2009: Hulin Cyrille; Facon Thierry; Rodon Philippe; Pegourie Brigitte; Benboubker Lotfi; Doyen Chantal; Dib Mamoun; Guillerm Gaelle; Salles Bruno; Eschard Jean-Paul; Lenain Pascal; Casassus Philippe; Azaïs Isabelle; Decaux Olivier; Garderet Laurent; Mathiot Claire; Fontan Jean; Lafon Ingrid; Virion Jean Marc; Moreau Philippe
Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(22):3664-70.
-
2009: Descamps G; Gomez-Bougie P; Venot C; Moreau P; Bataille R; Amiot M
A humanised anti-IGF-1R monoclonal antibody (AVE1642) enhances Bortezomib-induced apoptosis in myeloma cells lacking CD45.
British journal of cancer 2009;100(2):366-9.
-
2008: Moreau Philippe; Coiteux Valerie; Hulin Cyrille; Leleu Xavier; van de Velde Helgi; Acharya Milin; Harousseau Jean-Luc
Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma.
Haematologica 2008;93(12):1908-11.
-
2008: Ménoret Emmanuelle; Maïga Sophie; Descamps Géraldine; Pellat-Deceunynck Catherine; Fraslon Caroline; Cappellano Melania; Moreau Philippe; Bataille Régis; Amiot Martine
IL-21 stimulates human myeloma cell growth through an autocrine IGF-1 loop.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(10):6837-42.
-
2008: Moreau Philippe; Hulin Cyrille; Facon Thierry
Frontline treatment of multiple myeloma in elderly patients.
Blood reviews 2008;22(6):303-9.
-
2008: Moreau Philippe; Contu Licinio; Alba Francesco; Lai Sara; Simoes Renata; Orrù Sandro; Carcassi Carlo; Roger Michel; Rabreau Michèle; Carosella Edgardo D
HLA-G gene polymorphism in human placentas: possible association of G*0106 allele with preeclampsia and miscarriage.
Biology of reproduction 2008;79(3):459-67.
-
2008: Carosella Edgardo D; Moreau Philippe; Lemaoult Joël; Rouas-Freiss Nathalie
HLA-G: from biology to clinical benefits.
Trends in immunology 2008;29(3):125-32.
-
2008: Guillard Christine; Zidi Inès; Marcou Céline; Menier Catherine; Carosella Edgardo D; Moreau Philippe
Role of HLA-G in innate immunity through direct activation of NF-kappaB in natural killer cells.
Molecular immunology 2008;45(2):419-27.
-
2007: Rouas-Freiss Nathalie; Moreau Philippe; Menier Catherine; LeMaoult Joël; Carosella Edgardo D
Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.
Seminars in cancer biology 2007;17(6):413-21.
-
2007: Le Gouill Steven; Talmant Pascaline; Touzeau Cyrille; Moreau Anne; Garand Richard; Juge-Morineau Nadine; Gaillard Fanny; Gastinne Thomas; Milpied Noël; Moreau Philippe; Harousseau Jean Luc; Avet-Loiseau Hervé
The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Haematologica 2007;92(10):1335-42.
-
2007: Jaccard Arnaud; Moreau Philippe; Leblond Veronique; Leleu Xavier; Benboubker Lotfi; Hermine Olivier; Recher Christian; Asli Bouchra; Lioure Bruno; Royer Bruno; Jardin Fabrice; Bridoux Frank; Grosbois Bernard; Jaubert Jérome; Piette Jean-Charles; Ronco Pierre; Quet Fabrice; Cogne Michel; Fermand Jean-Paul;
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
The New England journal of medicine 2007;357(11):1083-93.
-
2007: Sangrouber Déborah; Marcou Céline; Le Discorde Magali; Chang Chien-Chung; Carosella Edgardo D; Moreau Philippe
Cellular co-localization of intron-4 containing mRNA and HLA-G soluble protein in melanoma analyzed by fluorescence in situ hybridization.
Journal of immunological methods 2007;326(1-2):54-62.
-
2007: Moreau P; Attal M; Garban F; Hulin C; Facon T; Marit G; Michallet M; Doyen C; Leyvraz S; Mohty M; Wetterwald M; Mathiot C; Caillot D; Berthou C; Benboubker L; Garderet L; Chaleteix C; Traullé C; Fuzibet J G; Jaubert J; Lamy T; Casassus P; Dib M; Kolb B; Dorvaux V; Grosbois B; Yakoub-Agha I; Harousseau J L; Avet-Loiseau H;
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(9):2020-4.
-
2007: Mégret Françoise; Prehaud Christophe; Lafage Mireille; Moreau Philippe; Rouas-Freiss Nathalie; Carosella Edgardo D; Lafon Monique
Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections.
Human immunology 2007;68(4):294-302.
-
2007: Mouillot Gaël; Marcou Céline; Zidi Inès; Guillard Christine; Sangrouber Déborah; Carosella Edgardo D; Moreau Philippe
Hypoxia modulates HLA-G gene expression in tumor cells.
Human immunology 2007;68(4):277-85.
-
2007: Moreau P; Voillat L; Benboukher L; Mathiot C; Dumontet C; Robillard N; Hérault O; Garnache F; Garand R; Varoqueaux N; Avet-Loiseau H; Harousseau J L; Bataille R;
Rituximab in CD20 positive multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(4):835-6.
-
2007: Favier B; LeMaoult J; Rouas-Freiss N; Moreau P; Menier C; Carosella E D
Research on HLA-G: an update.
Tissue antigens 2007;69(3):207-11.
-
2007: Caumartin Julien; Favier Benoit; Daouya Marina; Guillard Christine; Moreau Philippe; Carosella Edgardo D; LeMaoult Joel
Trogocytosis-based generation of suppressive NK cells.
The EMBO journal 2007;26(5):1423-33.
-
2007: Touzeau C; Pellat-Deceunynck C; Gastinne T; Accard F; Jego G; Avet-Loiseau H; Robillard N; Harousseau J L; Bataille R; Moreau P
Reactive plasmacytoses can mimick plasma cell leukemia: therapeutical implications.
Leukemia & lymphoma 2007;48(1):207-8.
-
2006: Zidi I; Guillard C; Marcou C; Krawice-Radanne I; Sangrouber D; Rouas-Freiss N; Carosella E D; Moreau P
Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.
Cellular and molecular life sciences : CMLS 2006;63(22):2669-81.
-
2006: Harousseau Jean-Luc; Attal Michel; Leleu Xavier; Troncy Jacques; Pegourie Brigitte; Stoppa Anne-Marie; Hulin Cyrille; Benboubker Lofti; Fuzibet Jean-Gabriel; Renaud Marc; Moreau Philippe; Avet-Loiseau Hervé
Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study.
Haematologica 2006;91(11):1498-505.
-
2006: Attal Michel; Harousseau Jean-Luc; Leyvraz Serge; Doyen Chantal; Hulin Cyrille; Benboubker Lofti; Yakoub Agha Ibrahim; Bourhis Jean-Henri; Garderet Laurent; Pegourie Brigitte; Dumontet Charles; Renaud Marc; Voillat Laurent; Berthou Christian; Marit Gerald; Monconduit Mathieu; Caillot Denis; Grobois Bernard; Avet-Loiseau Herve; Moreau Philippe; Facon Thierry;
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.
Blood 2006;108(10):3289-94.
-
2006: Menoret Emmanuelle; Gomez-Bougie Patricia; Geffroy-Luseau Alexandrine; Daniels Sylvanne; Moreau Philippe; Le Gouill Steven; Harousseau Jean-Luc; Bataille Regis; Amiot Martine; Pellat-Deceunynck Catherine
Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells.
Blood 2006;108(4):1346-52.
-
2006: Vigouroux Stéphane; Morin Odile; Moreau Philippe; Harousseau Jean-Luc; Milpied Noel
Candidemia in patients with hematologic malignancies: analysis of 7 years' experience in a single center.
Haematologica 2006;91(5):717-8.
-
2006: Garban Frederic; Attal Michel; Michallet Mauricette; Hulin Cyrille; Bourhis Jean H; Yakoub-Agha Ibrahim; Lamy Thierry; Marit Gerald; Maloisel Frederic; Berthou Christian; Dib Mamoun; Caillot Denis; Deprijck Bernard; Ketterer Nicolas; Harousseau Jean-Luc; Sotto Jean-Jacques; Moreau Philippe
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma.
Blood 2006;107(9):3474-80.
-
2006: Moreau Philippe; Robillard Nelly; Jégo Gaétan; Pellat Catherine; Le Gouill Steven; Thoumi Soraya; Avet-Loiseau Hervé; Harousseau Jean-Luc; Bataille Régis
Lack of CD27 in myeloma delineates different presentation and outcome.
British journal of haematology 2006;132(2):168-70.
-
2006: Moreau Philippe; Hullin Cyrille; Garban Frédéric; Yakoub-Agha Ibrahim; Benboubker Lotfi; Attal Michel; Marit Gérald; Fuzibet Jean-Gabriel; Doyen Chantal; Voillat Laurent; Berthou Christian; Ketterer Nicolas; Casassus Philippe; Monconduit Mathieu; Michallet Mauricette; Najman Albert; Sotto Jean-Jacques; Bataille Régis; Harousseau Jean-Luc;
Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol.
Blood 2006;107(1):397-403.
-
2005: Lafon Monique; Prehaud Christophe; Megret Françoise; Lafage Mireille; Mouillot Gaël; Roa Michèle; Moreau Philippe; Rouas-Freiss Nathalie; Carosella Edgardo D
Modulation of HLA-G expression in human neural cells after neurotropic viral infections.
Journal of virology 2005;79(24):15226-37.
-
2005: Rouas-Freiss Nathalie; Moreau Philippe; Ferrone Soldano; Carosella Edgardo D
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
Cancer research 2005;65(22):10139-44.
-
2005: Rouas-Freiss Nathalie; Bruel Sylvie; Menier Catherine; Marcou Céline; Moreau Philippe; Carosella Edgardo D
Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis.
International journal of cancer. Journal international du cancer 2005;117(1):114-22.
-
2005: Harousseau Jean-Luc; Moreau Philippe
Evolving role of stem cell transplantation in multiple myeloma.
Clinical lymphoma & myeloma 2005;6(2):89-95.
-
2005: Chevallier Patrice; Roland Virginie; Mahé Béatrice; Juge-Morineau Nadine; Dubruille Viviane; Guillaume Thierry; Vigouroux Stéphane; Moreau Philippe; Milpied Noël; Garand Richard; Avet-Loiseau Herve; Harousseau Jean-Luc
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Leukemia research 2005;29(9):1003-7.
-
2005: González-Hernandez Alvaro; LeMaoult Joël; Lopez Ana; Alegre Estibaliz; Caumartin Julien; Le Rond Solène; Daouya Marina; Moreau Philippe; Carosella Edgardo D
Linking two immuno-suppressive molecules: indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression.
Biology of reproduction 2005;73(3):571-8.
-
2005: Le Discorde Magali; Le Danff Caroline; Moreau Philippe; Rouas-Freiss Nathalie; Carosella Edgardo D
HLA-G*0105N null allele encodes functional HLA-G isoforms.
Biology of reproduction 2005;73(2):280-8.
-
2005: Wuillème-Toumi S; Robillard N; Gomez P; Moreau P; Le Gouill S; Avet-Loiseau H; Harousseau J-L; Amiot M; Bataille R
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1248-52.
-
2005: Mouillot Gaël; Marcou Céline; Rousseau Philippe; Rouas-Freiss Nathalie; Carosella Edgardo D; Moreau Philippe
HLA-G gene activation in tumor cells involves cis-acting epigenetic changes.
International journal of cancer. Journal international du cancer 2005;113(6):928-36.
-
2005: Vigouroux Stéphane; Morin Odile; Moreau Philippe; Méchinaud Françoise; Morineau Nadine; Mahé Béatrice; Chevallier Patrice; Guillaume Thierry; Dubruille Viviane; Harousseau Jean-Luc; Milpied Noël
Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(4):e35-7.
-
2004: Blin Nicolas; Morineau Nadine; Gaillard Fanny; Morin Odile; Milpied Noël; Harousseau Jean-Luc; Moreau Philippe
Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2004;45(10):2161-3.
-
2004: Moreau Philippe; Robillard Nelly; Avet-Loiseau Herve; Pineau Danielle; Morineau Nadine; Milpied Noel; Harousseau Jean-Luc; Bataille Regis
Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma.
Haematologica 2004;89(5):547-51.
-
2004: Le Maoult J; Rouas-Freiss N; Le Discorde M; Moreau P; Carosella E D
[HLA-G in organ transplantation]
Pathologie-biologie 2004;52(2):97-103.
-
2004: Rousseau Philippe; Masternak Krzysztof; Krawczyk Michal; Reith Walter; Dausset Jean; Carosella Edgardo D; Moreau Philippe
In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.
Immunology 2004;111(1):53-65.
-
2003: Le Discorde Magali; Moreau Philippe; Sabatier Patrick; Legeais Jean-Marc; Carosella Edgardo D
Expression of HLA-G in human cornea, an immune-privileged tissue.
Human immunology 2003;64(11):1039-44.
-
2003: Rousseau Philippe; Le Discorde Magali; Mouillot Gaël; Marcou Céline; Carosella Edgardo D; Moreau Philippe
The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability.
Human immunology 2003;64(11):1005-10.
-
2003: Rouas-Freiss Nathalie; Moreau Philippe; Menier Catherine; Carosella Edgardo D
HLA-G in cancer: a way to turn off the immune system.
Seminars in cancer biology 2003;13(5):325-36.
-
2003: Garand R; Avet-Loiseau H; Accard F; Moreau P; Harousseau J L; Bataille R
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(10):2032-5.
-
2003: LeMaoult J; Le Discorde M; Rouas-Freiss N; Moreau P; Menier C; McCluskey J; Carosella E D
Biology and functions of human leukocyte antigen-G in health and sickness.
Tissue antigens 2003;62(4):273-84.
-
2003: Robillard Nelly; Avet-Loiseau Herve; Garand Richard; Moreau Philippe; Pineau Danielle; Rapp Marie-Josee; Harousseau Jean-Luc; Bataille Regis
CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma.
Blood 2003;102(3):1070-1.
-
2003: Solary Eric; Drenou Bernard; Campos Lydia; de Crémoux Patricia; Mugneret Francine; Moreau Philippe; Lioure Bruno; Falkenrodt Annie; Witz Brigitte; Bernard Marc; Hunault-Berger Mathilde; Delain Martine; Fernandes José; Mounier Christiane; Guilhot François; Garnache Francine; Berthou Christian; Kara-Slimane Fawzi; Harousseau Jean-Luc;
Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia.
Blood 2003;102(4):1202-10.
-
2003: Mahé B; Milpied N; Mellerin M P; Moreau P; Morineau N; Vigier M; Harousseau J L
PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
Bone marrow transplantation 2003;31(6):467-73.
-
2003: Moreau Philippe; Mouillot Gael; Rousseau Philippe; Marcou Celine; Dausset Jean; Carosella Edgardo D
HLA-G gene repression is reversed by demethylation.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(3):1191-6.
-
2003: Rouas-Freiss Nathalie; LeMaoult Joël; Moreau Philippe; Dausset Jean; Carosella Edgardo D
HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(1):11-6.
-
2003: Carosella Edgardo D; Moreau Philippe; Le Maoult Joël; Le Discorde Magali; Dausset Jean; Rouas-Freiss Nathalie
HLA-G molecules: from maternal-fetal tolerance to tissue acceptance.
Advances in immunology 2003;81():199-252.
-
2002: Moreau Philippe; Dausset Jean; Carosella Edgardo D; Rouas-Freiss Nathalie
Viewpoint on the functionality of the human leukocyte antigen-G null allele at the fetal-maternal interface.
Biology of reproduction 2002;67(5):1375-8.
-
2002: Moreau P; Rousseau P; Rouas-Freiss N; Le Discorde M; Dausset J; Carosella E D
HLA-G protein processing and transport to the cell surface.
Cellular and molecular life sciences : CMLS 2002;59(9):1460-6.
-
2002: Moreau P; Misbahi R; Milpied N; Morineau N; Mahé B; Vigier M; Rapp M J; Bataille R; Harousseau J L
Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1838-43.
-
2002: Moreau Philippe; Facon Thierry; Leleu Xavier; Morineau Nadine; Huyghe Pauline; Harousseau Jean-Luc; Bataille Régis; Avet-Loiseau Hervé;
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy.
Blood 2002;100(5):1579-83.
-
2002: Vigouroux S; Milpied N; Andrieu J M; Colonna P; Ifrah N; Colombat P; Desablens B; Abgrall J F; Casassus P; Guilhot F; Briere J; Le Mevel A; Moreau P; Mechinaud F; Mahe B; Morineau N; Vigier M; Rapp M J; Harousseau J L
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy.
Bone marrow transplantation 2002;29(10):833-42.
-
2002: Le Discorde M; Moreau P; Rouas-Freiss N; Carosella E
[HLA-G: immune tolerance in normal and pathological physiology]
Pathologie-biologie 2002;50(1):45-51.
-
2002: Moreau Philippe; Facon Thierry; Attal Michel; Hulin Cyrille; Michallet Mauricette; Maloisel Frédéric; Sotto Jean-Jacques; Guilhot François; Marit Gérald; Doyen Chantal; Jaubert Jérôme; Fuzibet Jean-Gabriel; François Sylvie; Benboubker Lotfi; Monconduit Matthieu; Voillat Laurent; Macro Margaret; Berthou Christian; Dorvaux Véronique; Pignon Bernard; Rio Bernard; Matthes Thomas; Casassus Philippe; Caillot Denis; Najman Norbert; Grosbois Bernard; Bataille Régis; Harousseau Jean-Luc;
Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial.
Blood 2002;99(3):731-5.
-
2002: Chevallier Patrice; Penther Dominique; Avet-Loiseau Hervé; Robillard Nelly; Ifrah Norbert; Mahé Béatrice; Hamidou Mohamed; Maisonneuve Hervé; Moreau Philippe; Jardel Henri; Harousseau Jean Luc; Bataille Régis; Garand Richard
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
British journal of haematology 2002;116(1):142-50.
-
2002: Yakoub-Agha Ibrahim; Attal Michel; Dumontet Charles; Delannoy Válerie; Moreau Philippe; Berthou Christian; Lamy Thierney; Grosbois Bernard; Dauriac Charly; Dorvaux Véronique; Bay Jacques-Olivier; Monconduit Matthieu; Harousseau Jean Luc; Duguet Corinne; Duhamel Alain; Facon Thierry
Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myélome (IFM).
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(4):185-92.
-
2001: O'Brien M; McCarthy T; Jenkins D; Paul P; Dausset J; Carosella E D; Moreau P
Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease.
Cellular and molecular life sciences : CMLS 2001;58(12-13):1943-9.
-
2001: Michallet M; Bilger K; Garban F; Attal M; Huyn A; Blaise D; Milpied N; Moreau P; Bordigoni P; Kuentz M; Sadoun A; Cahn J Y; Socié G; Thomas X; Arnaud P; Raus N; Lhéritier V; Pigneux A; Boiron J M
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3340-9.
-
2001: Ninin E; Milpied N; Moreau P; André-Richet B; Morineau N; Mahé B; Vigier M; Imbert B M; Morin O; Harousseau J L; Richet H
Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(1):41-7.
-
2001: Riteau B; Moreau P; Menier C; Khalil-Daher I; Khosrotehrani K; Bras-Goncalves R; Paul P; Dausset J; Rouas-Freiss N; Carosella E D
Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line.
Transplantation proceedings 2001;33(3):2360-4.
-
2001: Moreau P; Faure O; Lefebvre S; Ibrahim E C; O'Brien M; Gourand L; Dausset J; Carosella E D; Paul P
Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts.
Transplantation proceedings 2001;33(3):2277-80.
-
2001: Lefebvre S; Berrih-Aknin S; Adrian F; Moreau P; Poea S; Gourand L; Dausset J; Carosella E D; Paul P
A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta.
The Journal of biological chemistry 2001;276(9):6133-9.
-
2001: Thomas O; Mahé M; Campion L; Bourdin S; Milpied N; Brunet G; Lisbona A; Le Mevel A; Moreau P; Harousseau J; Cuillière J
Long-term complications of total body irradiation in adults.
International journal of radiation oncology, biology, physics 2001;49(1):125-31.
-
2000: Carosella E D; Paul P; Moreau P; Rouas-Freiss N
HLA-G and HLA-E: fundamental and pathophysiological aspects.
Immunology today 2000;21(11):532-4.
-
2000: Paul P; Rouas-Freiss N; Moreau P; Cabestre F A; Menier C; Khalil-Daher I; Pangault C; Onno M; Fauchet R; Martinez-Laso J; Morales P; Villena A A; Giacomini P; Natali P G; Frumento G; Ferrara G B; McMaster M; Fisher S; Schust D; Ferrone S; Dausset J; Geraghty D; Carosella E D
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.
Human immunology 2000;61(11):1177-95.
-
2000: Rousseau P; Paul P; O'Brien M; Dausset J; Carosella E D; Moreau P
The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors.
Human immunology 2000;61(11):1132-7.
-
2000: O'Brien M; Dausset J; Carosella E D; Moreau P
Analysis of the role of HLA-G in preeclampsia.
Human immunology 2000;61(11):1126-31.
-
2000: Lefebvre S; Adrian F; Moreau P; Gourand L; Dausset J; Berrih-Aknin S; Carosella E D; Paul P
Modulation of HLA-G expression in human thymic and amniotic epithelial cells.
Human immunology 2000;61(11):1095-101.
-
2000: Morineau N; Tang X W; Moreau P; Milpied N; Mahé B; Bataille R; Harousseau J L
Lack of benefit of CD34+ cell selected over non-selected peripheral blood stem cell transplantation in multiple myeloma: results of a single center study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(10):1815-20.
-
2000: Jego G; Avet-Loiseau H; Robillard N; Moreau P; Amiot M; Harousseau J; Pellat-Deceunynck C; Bataille R
Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF.
Leukemia research 2000;24(7):627-30.
-
2000: Mahé M a; Bourdin S; Le Pourhiet-Le Mevel A; Moreau P; Campion L; Hamidou M; Milpied N; Moreau A; Gaillard F; Harousseau J L; Cuillière J C
Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapy.
International journal of radiation oncology, biology, physics 2000;47(3):735-8.
-
2000: Le Gouill S; Talmant P; Milpied N; Daviet A; Ancelot M; Moreau P; Harousseau J L; Bataille R; Avet-Loiseau H
Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(7):1533-8.
-
2000: Yakoub-Agha I; Moreau P; Leyvraz S; Berthou C; Payen C; Dumontet C; Grosbois B; Beris P; Duguet C; Attal M; Harousseau J L; Facon T;
Thalidomide in patients with advanced multiple myeloma.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(3):186-9.
-
1999: Puthier D; Derenne S; Barillé S; Moreau P; Harousseau J L; Bataille R; Amiot M
Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.
British journal of haematology 1999;107(2):392-5.
-
1999: Barillé S; Thabard W; Robillard N; Moreau P; Pineau D; Harousseau J L; Bataille R; Amiot M
CD130 rather than CD126 expression is associated with disease activity in multiple myeloma.
British journal of haematology 1999;106(2):532-5.
-
1999: Lefebvre S; Moreau P; Guiard V; Ibrahim E C; Adrian-Cabestre F; Menier C; Dausset J; Carosella E D; Paul P
Molecular mechanisms controlling constitutive and IFN-gamma-inducible HLA-G expression in various cell types.
Journal of reproductive immunology 1999;43(2):213-24.
-
1999: Adrián Cabestré F; Moreau P; Riteau B; Ibrahim E C; Le Danff C; Dausset J; Rouas-Freiss N; Carosella E D; Paul P
HLA-G expression in human melanoma cells: protection from NK cytolysis.
Journal of reproductive immunology 1999;43(2):183-93.
-
1999: Moreau P; Milpied N; Mahé B; Juge-Morineau N; Rapp M J; Bataille R; Harousseau J L
Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma.
Bone marrow transplantation 1999;23(10):1003-6.
-
1999: Moreau P; Adrian-Cabestre F; Menier C; Guiard V; Gourand L; Dausset J; Carosella E D; Paul P
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes.
International immunology 1999;11(5):803-11.
-
1999: Lefebvre S; Moreau P; Dausset J; Carosella E D; Paul P
Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA.
Placenta 1999;20(4):293-301.
-
1999: Milpied N; Coste-Burel M; Accard F; Moreau A; Moreau P; Garand R; Harousseau J L
Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation.
Bone marrow transplantation 1999;23(6):629-30.
-
1999: Moreau P; Huynh A; Facon T; Bouilly I; Sotto J J; Legros L; Milpied N; Attal M; Bataille R; Harousseau J L
Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM)
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(3):490-1.
-
1999: Cabestre F A; Lefebvre S; Moreau P; Rouas-Friess N; Dausset J; Carosella E D; Paul P
HLA-G expression: immune privilege for tumour cells?
Seminars in cancer biology 1999;9(1):27-36.
-
1998: Moreau P; Lefebvre S; Gourand L; Dausset J; Carosella E D; Paul P
Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver.
Human immunology 1998;59(12):751-7.
-
1998: Milpied N; Gaillard F; Moreau P; Mahé B; Souchet J; Rapp M J; Bulabois C E; Morineau N; Harousseau J L
High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience.
Bone marrow transplantation 1998;22(7):645-50.
-
1998: Moreau P; Paul P; Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella E D
Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
American journal of reproductive immunology (New York, N.Y. : 1989) 1998;40(3):136-44.
-
1998: Moreau P; Milpied N; Rapp M J; Moreau A; Bourdin S; Mahe M A; Dupas B; Le Tortorec S; Hamidou M; Maisoneuve H; Mahe B; Bulabois C E; Morineau N; Jardel H; Harousseau J L
Early intensive therapy with autologous stem cell transplantation in high-risk Hodgkin's disease: long-term follow-up in 35 cases.
Leukemia & lymphoma 1998;30(3-4):313-24.
-
1998: Moreau P; Milpied N; Voillat L; Colombat P; Mahé B; Rapp M J; Moreau A; Dupas B; Bulabois C E; Juge-Morineau N; Harousseau J L
Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study.
Bone marrow transplantation 1998;21(12):1193-6.
-
1998: Moreau P; Leblond V; Bourquelot P; Facon T; Huynh A; Caillot D; Hermine O; Attal M; Hamidou M; Nedellec G; Ferrant A; Audhuy B; Bataille R; Milpied N; Harousseau J L
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients.
British journal of haematology 1998;101(4):766-9.
-
1998: Moreau P; Fleury J; Brice P; Colombat P; Bouabdallah R; Lioure B; Voillat L; Casasnovas O; François S; Sadoun A; Lamy T; Lotz J P; Munck J N; Divine M; Fermé C; Pény A M; Fruchart C; Oriol P; Ojeda M; Reman O; Milpied N; Gisselbrecht C; Legros M; Harousseau J L
Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry.
Bone marrow transplantation 1998;21(8):787-93.
-
1998: Mahé M A; Bourdin S; Le Mevel A; Moreau P; Moreau A; Hamidou M; Gaillard F; Rapp M J; Milpied N; Harousseau J L
Long-term results of total abdominopelvic irradiation in non-Hodgkin's lymphomas after failure of chemotherapy.
International journal of radiation oncology, biology, physics 1998;41(1):117-21.
-
1998: Paul P; Rouas-Freiss N; Khalil-Daher I; Moreau P; Riteau B; Le Gal F A; Avril M F; Dausset J; Guillet J G; Carosella E D
HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(8):4510-5.
-
1997: Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
Bone marrow transplantation 1997;20(1):21-6.
-
1997: Brice P; Bastion Y; Lepage E; Brousse N; Haïoun C; Moreau P; Straetmans N; Tilly H; Tabah I; Solal-Céligny P
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1110-7.
-
1997: Moreau P; Fiere D; Bezwoda W R; Facon T; Attal M; Laporte J P; Colombat P; Haak H L; Monconduit M; Lockhorst H; Girault D; Harousseau J L
Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):660-6.
-
1997: Moreau P; Paul P; Gourand L; Prost S; Dausset J; Carosella E; Kirszenbaum M
HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1.
Human immunology 1997;52(1):41-6.
-
1996: Moreau P; Kergueris M F; Milpied N; Le Tortorec S; Mahé B; Bulabois C E; Rapp M J; Larousse C; Bataille R; Harousseau J L
A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity.
British journal of haematology 1996;95(3):527-30.
-
1996: Moreau P; Méchinaud F; Mahé B; Le Tortorec S; Rapp M J; Maisonneuve H; Harousseau J L; Milpied N
Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two cases of aggressive high-grade non-Hodgkin's lymphoma.
Bone marrow transplantation 1996;18(3):665-7.
-
1996: Solary E; Witz B; Caillot D; Moreau P; Desablens B; Cahn J Y; Sadoun A; Pignon B; Berthou C; Maloisel F; Guyotat D; Casassus P; Ifrah N; Lamy Y; Audhuy B; Colombat P; Harousseau J L
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study.
Blood 1996;88(4):1198-205.
-
1996: Mahé B; Milpied N; Hermouet S; Robillard N; Moreau P; Letortorec S; Rapp M J; Bataille R; Harousseau J L
G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma.
British journal of haematology 1996;92(2):263-8.
-
1995: Mahé B; Gaillard F; Labadie F; Papin S; Letortorec S; Moreau P; Harousseau J L; Milpied N
Occurrence of a T cell lymphoma in a patient with chronic myeloid leukemia treated with alpha interferon.
Leukemia & lymphoma 1995;19(5-6):515-7.
-
1995: Teyssier M; Bensussan A; Kirszenbaum M; Moreau P; Gluckman E; Dausset J; Carosella E
Natural killer cells are the unique lymphocyte cell subset which do not express HLA-G.
Natural immunity 1995;14(5-6):262-70.
-
1995: Moreau P; Carosella E; Gluckman E; Gourand L; Prost S; Dausset J; Kirszenbaum M
[Alternative transcripts of the MHC of the non-classical class I HLA-G gene in the in trophoblast during the first pregnancy trimester and in the placenta at term]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1995;318(8):837-42.
-
1995: Kirszenbaum M; Moreau P; Teyssier M; Lafon C; Gluckman E; Dausset J; Carosella E
Evidence for the presence of the alternatively spliced HLA-G mRNA forms in human mononuclear cells from peripheral blood and umbilical cord blood.
Human immunology 1995;43(3):237-41.
-
1995: Moreau P; Carosella E; Teyssier M; Prost S; Gluckman E; Dausset J; Kirszenbaum M
Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts.
Human immunology 1995;43(3):231-6.
-
1995: Mahé B; Moreau A; Moreau P; Le Tortorec S; Harousseau J L; Milpied N
High dose radiochemotherapy followed by autologous stem cell transplantation in four patients with multiple lymphomatous polyposis.
Cancer 1995;75(11):2742-6.
-
1994: Moreau P; Le Tortorec S; Mahé B; Legros L; Milpied N; Harousseau J L
Administration of granulocyte colony-stimulating factor from day 7 after autologous bone marrow transplantation: effects on neutropenia and duration of hospitalization.
Nouvelle revue française d'hématologie 1994;36(6):455-8.
-
1994: Moreau P; LeTortorec S; Mahé M A; Mahé B; Moreau A; Bourdin S; Bulabois C E; Bureau B; Harousseau J L; Milpied N
Autologous bone marrow transplantation using TBI and CBV for disseminated high/intermediate grade cutaneous non-epidermotropic non-Hodgkin's lymphoma.
Bone marrow transplantation 1994;14(5):775-8.
-
1994: Wu D P; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp M J; Bourdin S; Mahe J M; Harousseau J L
Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Bone marrow transplantation 1994;14(5):751-7.
-
1994: Mahé B; Moreau P; Bonnemain B; Letortorec S; Menegali D; Bourdin S; De Lajartre D; Harousseau J L
Isolated Richter's syndrome of the brain: two recent cases.
Nouvelle revue française d'hématologie 1994;36(5):383-5.
-
1994: Mahe B; Moreau P; Le Tortorec S; Hourmant M; Harousseau J L; Milpied N
Autologous bone marrow transplantation for cyclosporin-related lymphoma in a renal transplant patient.
Bone marrow transplantation 1994;14(4):645-6.
-
1994: Kirszenbaum M; Moreau P; Gluckman E; Dausset J; Carosella E
An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(10):4209-13.
-
1994: Moreau P; Teyssier M; Kirszenbaum M; Gluckman E; Gourand L; Carosella E; Dausset J
HLA-G mRNA forms in human trophoblasts and peripheral blood lymphocytes: potential use in prenatal diagnosis.
Folia biologica 1994;40(6):431-8.
-
1993: Moreau P; Milpied N; Mechinaud-Lacroix F; Mahe B; Rapp M J; Le Tortorec S; Bourdin S; Dupas B; Harousseau J L
Early intensive therapy with autotransplantation for high-risk Hodgkin's disease.
Leukemia & lymphoma 1993;12(1-2):51-8.
-
1991: Moreau P; Talmant P; Milpied N; Garand R; Lefranc G; Harousseau J L
Trisomy 4 associated with acute lymphocytic leukaemia.
British journal of haematology 1991;78(4):576.
Sign-in to see more